Stephen Daniel Bacchi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 15 | 2024 | 1134 | 3.530 |
Why?
|
Artificial Intelligence | 18 | 2024 | 2551 | 3.080 |
Why?
|
Australia | 28 | 2024 | 1276 | 2.710 |
Why?
|
Ophthalmology | 12 | 2024 | 549 | 1.900 |
Why?
|
Rural Health Services | 7 | 2024 | 381 | 1.750 |
Why?
|
Stroke | 15 | 2024 | 9694 | 1.680 |
Why?
|
Students, Medical | 9 | 2024 | 1927 | 1.600 |
Why?
|
Patient Discharge | 8 | 2024 | 3433 | 1.560 |
Why?
|
Myasthenia Gravis | 4 | 2023 | 212 | 1.550 |
Why?
|
Illusions | 2 | 2024 | 60 | 1.110 |
Why?
|
Penicillins | 5 | 2024 | 406 | 1.030 |
Why?
|
Vital Signs | 2 | 2024 | 144 | 1.030 |
Why?
|
Length of Stay | 7 | 2024 | 6439 | 1.020 |
Why?
|
Electronic Health Records | 11 | 2024 | 4761 | 0.990 |
Why?
|
Hypersensitivity | 5 | 2023 | 1155 | 0.920 |
Why?
|
Resuscitation Orders | 2 | 2024 | 270 | 0.910 |
Why?
|
Inpatients | 5 | 2024 | 2551 | 0.880 |
Why?
|
Brain Ischemia | 6 | 2023 | 3047 | 0.870 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2024 | 985 | 0.860 |
Why?
|
Humans | 169 | 2024 | 758406 | 0.840 |
Why?
|
Hygiene | 1 | 2023 | 94 | 0.830 |
Why?
|
Licensure | 1 | 2023 | 128 | 0.820 |
Why?
|
Hospitals, Rural | 1 | 2024 | 174 | 0.820 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2023 | 664 | 0.800 |
Why?
|
General Practice | 1 | 2023 | 96 | 0.800 |
Why?
|
Guillain-Barre Syndrome | 1 | 2023 | 126 | 0.770 |
Why?
|
Consciousness | 3 | 2023 | 601 | 0.760 |
Why?
|
Unconsciousness | 1 | 2023 | 250 | 0.760 |
Why?
|
Valproic Acid | 1 | 2024 | 442 | 0.750 |
Why?
|
Computers | 1 | 2023 | 596 | 0.720 |
Why?
|
Drug Hypersensitivity | 3 | 2024 | 915 | 0.710 |
Why?
|
Hematinics | 1 | 2023 | 280 | 0.710 |
Why?
|
Resilience, Psychological | 2 | 2020 | 772 | 0.710 |
Why?
|
Clinical Coding | 1 | 2021 | 180 | 0.700 |
Why?
|
Risk Management | 1 | 2023 | 557 | 0.690 |
Why?
|
Anaphylaxis | 2 | 2024 | 755 | 0.650 |
Why?
|
Arterial Occlusive Diseases | 1 | 2023 | 747 | 0.630 |
Why?
|
Rural Population | 4 | 2024 | 2254 | 0.610 |
Why?
|
Epilepsy | 2 | 2024 | 3269 | 0.600 |
Why?
|
Food | 1 | 2023 | 771 | 0.600 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 878 | 0.580 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2018 | 118 | 0.580 |
Why?
|
Hypotension, Orthostatic | 2 | 2019 | 256 | 0.580 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5331 | 0.580 |
Why?
|
Domperidone | 1 | 2017 | 24 | 0.570 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.570 |
Why?
|
Hand | 1 | 2022 | 903 | 0.560 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2017 | 80 | 0.550 |
Why?
|
Defibrillators | 4 | 2023 | 39 | 0.550 |
Why?
|
Checklist | 1 | 2024 | 827 | 0.550 |
Why?
|
Physical Examination | 1 | 2022 | 1245 | 0.530 |
Why?
|
Glucocorticoids | 3 | 2024 | 2144 | 0.530 |
Why?
|
South Australia | 6 | 2024 | 26 | 0.530 |
Why?
|
Cerebrovascular Disorders | 2 | 2023 | 1475 | 0.530 |
Why?
|
Students | 3 | 2023 | 1734 | 0.520 |
Why?
|
Dopamine Antagonists | 1 | 2017 | 288 | 0.520 |
Why?
|
Patient Readmission | 4 | 2024 | 3261 | 0.510 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 327 | 0.490 |
Why?
|
Education, Medical | 3 | 2024 | 1725 | 0.480 |
Why?
|
Hospital Mortality | 3 | 2024 | 5272 | 0.470 |
Why?
|
Algorithms | 9 | 2024 | 13961 | 0.470 |
Why?
|
Statistics as Topic | 1 | 2021 | 2359 | 0.470 |
Why?
|
Seizures | 2 | 2024 | 2919 | 0.460 |
Why?
|
Forecasting | 2 | 2021 | 2923 | 0.460 |
Why?
|
Anticonvulsants | 1 | 2024 | 1881 | 0.460 |
Why?
|
New Zealand | 5 | 2024 | 352 | 0.440 |
Why?
|
Education, Medical, Undergraduate | 2 | 2024 | 1066 | 0.430 |
Why?
|
Pilot Projects | 8 | 2024 | 8553 | 0.430 |
Why?
|
Stress, Psychological | 2 | 2020 | 4455 | 0.420 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2567 | 0.420 |
Why?
|
Retrospective Studies | 28 | 2024 | 80168 | 0.410 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2139 | 0.410 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1647 | 0.410 |
Why?
|
Palliative Care | 2 | 2024 | 3570 | 0.400 |
Why?
|
Hospitalization | 5 | 2023 | 10652 | 0.380 |
Why?
|
Curriculum | 5 | 2024 | 3717 | 0.360 |
Why?
|
General Surgery | 5 | 2024 | 1677 | 0.350 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36284 | 0.320 |
Why?
|
Autoantibodies | 1 | 2018 | 2118 | 0.320 |
Why?
|
Thrombectomy | 3 | 2024 | 690 | 0.310 |
Why?
|
Electroencephalography | 1 | 2024 | 6187 | 0.310 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1462 | 0.300 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5103 | 0.300 |
Why?
|
Area Under Curve | 3 | 2021 | 1632 | 0.290 |
Why?
|
Databases, Bibliographic | 2 | 2018 | 130 | 0.280 |
Why?
|
Registries | 1 | 2023 | 8175 | 0.280 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3339 | 0.270 |
Why?
|
Aged | 20 | 2024 | 168218 | 0.270 |
Why?
|
Educational Measurement | 2 | 2024 | 1248 | 0.270 |
Why?
|
Parkinson Disease | 2 | 2019 | 2862 | 0.270 |
Why?
|
Cultural Diversity | 3 | 2024 | 365 | 0.270 |
Why?
|
Medicare | 2 | 2023 | 6741 | 0.260 |
Why?
|
Physicians | 1 | 2023 | 4580 | 0.250 |
Why?
|
Telemedicine | 1 | 2023 | 3018 | 0.250 |
Why?
|
Vitreoretinal Surgery | 1 | 2024 | 28 | 0.240 |
Why?
|
Anticoagulants | 4 | 2023 | 4777 | 0.240 |
Why?
|
Food Service, Hospital | 1 | 2024 | 18 | 0.240 |
Why?
|
Glioma | 1 | 2019 | 3418 | 0.240 |
Why?
|
Camelids, New World | 1 | 2024 | 20 | 0.240 |
Why?
|
Universal Precautions | 1 | 2023 | 34 | 0.230 |
Why?
|
Middle Aged | 17 | 2024 | 219568 | 0.220 |
Why?
|
Rheumatic Fever | 1 | 2024 | 75 | 0.220 |
Why?
|
Intubation | 1 | 2024 | 139 | 0.220 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 72 | 0.220 |
Why?
|
Authorship | 2 | 2023 | 281 | 0.220 |
Why?
|
Electric Countershock | 2 | 2023 | 533 | 0.220 |
Why?
|
Reperfusion | 1 | 2024 | 270 | 0.220 |
Why?
|
Tramadol | 1 | 2023 | 60 | 0.220 |
Why?
|
Medical Audit | 1 | 2024 | 452 | 0.210 |
Why?
|
Surgery Department, Hospital | 1 | 2024 | 177 | 0.210 |
Why?
|
Male | 24 | 2024 | 358747 | 0.210 |
Why?
|
Rural Health | 1 | 2024 | 296 | 0.210 |
Why?
|
Decompressive Craniectomy | 1 | 2023 | 76 | 0.210 |
Why?
|
Respiratory Rate | 1 | 2024 | 175 | 0.210 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 165 | 0.210 |
Why?
|
Food Handling | 1 | 2023 | 155 | 0.210 |
Why?
|
Injections, Subcutaneous | 1 | 2024 | 677 | 0.200 |
Why?
|
Dupuytren Contracture | 1 | 2023 | 66 | 0.200 |
Why?
|
Hematologic Tests | 1 | 2023 | 238 | 0.200 |
Why?
|
Aerospace Medicine | 1 | 2023 | 95 | 0.200 |
Why?
|
Methylprednisolone | 1 | 2023 | 384 | 0.200 |
Why?
|
Triage | 2 | 2019 | 986 | 0.200 |
Why?
|
Linguistics | 1 | 2022 | 106 | 0.200 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 194 | 0.200 |
Why?
|
Time Factors | 5 | 2024 | 39872 | 0.200 |
Why?
|
Basilar Artery | 1 | 2023 | 204 | 0.200 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2023 | 242 | 0.200 |
Why?
|
Blepharoptosis | 1 | 2023 | 143 | 0.200 |
Why?
|
Breath Tests | 1 | 2023 | 297 | 0.200 |
Why?
|
Specialties, Surgical | 2 | 2024 | 388 | 0.200 |
Why?
|
Female | 23 | 2024 | 390323 | 0.200 |
Why?
|
Prognosis | 3 | 2024 | 29557 | 0.200 |
Why?
|
Antiemetics | 1 | 2023 | 187 | 0.200 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2023 | 86 | 0.190 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1915 | 0.190 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6457 | 0.190 |
Why?
|
Optic Neuritis | 1 | 2023 | 174 | 0.190 |
Why?
|
Adrenal Glands | 1 | 2024 | 554 | 0.190 |
Why?
|
Workflow | 2 | 2023 | 850 | 0.190 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 247 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9273 | 0.190 |
Why?
|
Cultural Competency | 1 | 2024 | 297 | 0.190 |
Why?
|
Preoperative Care | 3 | 2024 | 2249 | 0.180 |
Why?
|
Vasospasm, Intracranial | 1 | 2023 | 215 | 0.180 |
Why?
|
Costs and Cost Analysis | 2 | 2023 | 1673 | 0.180 |
Why?
|
Marketing | 1 | 2022 | 220 | 0.180 |
Why?
|
Intensive Care Units | 2 | 2024 | 3732 | 0.180 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2024 | 488 | 0.180 |
Why?
|
Epinephrine | 1 | 2024 | 790 | 0.180 |
Why?
|
Depression | 2 | 2023 | 8057 | 0.180 |
Why?
|
Vitrectomy | 1 | 2023 | 391 | 0.170 |
Why?
|
Blood Glucose | 2 | 2024 | 6346 | 0.170 |
Why?
|
Spirometry | 1 | 2023 | 923 | 0.170 |
Why?
|
Macular Edema | 1 | 2024 | 374 | 0.170 |
Why?
|
Waiting Lists | 1 | 2024 | 762 | 0.170 |
Why?
|
Patients' Rooms | 1 | 2020 | 61 | 0.170 |
Why?
|
Thyrotropin | 1 | 2023 | 832 | 0.170 |
Why?
|
Patients | 2 | 2023 | 904 | 0.170 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2023 | 617 | 0.170 |
Why?
|
Publishing | 2 | 2024 | 833 | 0.170 |
Why?
|
Language | 3 | 2024 | 1532 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 297 | 0.160 |
Why?
|
Pain, Postoperative | 3 | 2024 | 1721 | 0.160 |
Why?
|
Students, Nursing | 1 | 2019 | 45 | 0.160 |
Why?
|
Postoperative Complications | 6 | 2024 | 15637 | 0.160 |
Why?
|
Optic Nerve Diseases | 1 | 2023 | 342 | 0.160 |
Why?
|
Databases, Factual | 3 | 2024 | 7980 | 0.160 |
Why?
|
Training Support | 1 | 2019 | 108 | 0.160 |
Why?
|
Referral and Consultation | 2 | 2024 | 3586 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2023 | 465 | 0.160 |
Why?
|
Reading | 1 | 2022 | 529 | 0.160 |
Why?
|
Serotonin | 1 | 2023 | 1040 | 0.160 |
Why?
|
Conflict of Interest | 1 | 2023 | 548 | 0.160 |
Why?
|
Vitiligo | 1 | 2019 | 97 | 0.150 |
Why?
|
Eye Diseases | 2 | 2024 | 651 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 543 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8981 | 0.150 |
Why?
|
Hyperlipidemias | 1 | 2023 | 772 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1573 | 0.150 |
Why?
|
Health Literacy | 1 | 2023 | 441 | 0.150 |
Why?
|
Schools, Medical | 2 | 2024 | 877 | 0.150 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 549 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2023 | 960 | 0.140 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2023 | 781 | 0.140 |
Why?
|
Hypoglycemia | 1 | 2024 | 881 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1533 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 694 | 0.140 |
Why?
|
Environment | 1 | 2023 | 1118 | 0.140 |
Why?
|
Hydrocephalus | 1 | 2023 | 764 | 0.140 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7403 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 872 | 0.140 |
Why?
|
Appendicitis | 1 | 2023 | 674 | 0.140 |
Why?
|
False Positive Reactions | 1 | 2019 | 956 | 0.140 |
Why?
|
Reference Values | 1 | 2023 | 4919 | 0.130 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 821 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2772 | 0.130 |
Why?
|
Documentation | 1 | 2022 | 892 | 0.130 |
Why?
|
Otolaryngology | 1 | 2023 | 685 | 0.130 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 485 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2024 | 1368 | 0.130 |
Why?
|
Cooperative Behavior | 1 | 2023 | 1501 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1001 | 0.130 |
Why?
|
Risk Factors | 9 | 2024 | 73809 | 0.130 |
Why?
|
Universities | 2 | 2023 | 993 | 0.130 |
Why?
|
Carotid Stenosis | 1 | 2022 | 853 | 0.130 |
Why?
|
Intubation, Intratracheal | 1 | 2023 | 1327 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2024 | 1470 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1000 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2060 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58683 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2307 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1973 | 0.120 |
Why?
|
Prospective Studies | 7 | 2024 | 54137 | 0.120 |
Why?
|
Leadership | 1 | 2023 | 1371 | 0.120 |
Why?
|
Automobile Driving | 1 | 2019 | 438 | 0.120 |
Why?
|
Surgical Wound Infection | 1 | 2023 | 1526 | 0.110 |
Why?
|
Psychology | 1 | 2016 | 356 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 459 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1081 | 0.110 |
Why?
|
Orthopedics | 1 | 2023 | 892 | 0.110 |
Why?
|
Biomedical Research | 3 | 2024 | 3418 | 0.110 |
Why?
|
Software | 3 | 2022 | 4415 | 0.110 |
Why?
|
Risk-Taking | 1 | 2019 | 1034 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25956 | 0.110 |
Why?
|
Dermatology | 1 | 2023 | 914 | 0.110 |
Why?
|
Adult | 11 | 2024 | 219935 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3563 | 0.110 |
Why?
|
Internship and Residency | 2 | 2024 | 5865 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2024 | 2083 | 0.110 |
Why?
|
Patient Care Team | 1 | 2024 | 2504 | 0.110 |
Why?
|
Career Choice | 1 | 2019 | 752 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2115 | 0.110 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1415 | 0.100 |
Why?
|
Hospitals | 2 | 2024 | 3887 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2019 | 840 | 0.100 |
Why?
|
Wound Healing | 1 | 2023 | 2783 | 0.100 |
Why?
|
Heart Rate | 1 | 2024 | 4166 | 0.100 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2618 | 0.100 |
Why?
|
Risk Assessment | 3 | 2023 | 23884 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3603 | 0.100 |
Why?
|
Outpatients | 1 | 2019 | 1591 | 0.100 |
Why?
|
Clinical Competence | 2 | 2024 | 4775 | 0.100 |
Why?
|
Administration, Oral | 3 | 2023 | 3991 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 987 | 0.090 |
Why?
|
Hemorrhage | 1 | 2023 | 3400 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3765 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3858 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 825 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3082 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2023 | 64378 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1547 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1248 | 0.090 |
Why?
|
Logistic Models | 2 | 2023 | 13276 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1855 | 0.080 |
Why?
|
Vitamin D | 1 | 2023 | 3283 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3204 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2004 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2023 | 5404 | 0.080 |
Why?
|
Demography | 2 | 2024 | 1651 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12951 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1554 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3886 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2017 | 1297 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13468 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5065 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2055 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2248 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3024 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14641 | 0.070 |
Why?
|
United States | 3 | 2023 | 72136 | 0.070 |
Why?
|
Educational Status | 2 | 2023 | 2513 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4745 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3234 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5797 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4652 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22032 | 0.060 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 1 | 2023 | 23 | 0.060 |
Why?
|
Povidone-Iodine | 1 | 2023 | 55 | 0.060 |
Why?
|
Nimodipine | 1 | 2023 | 56 | 0.060 |
Why?
|
2-Propanol | 1 | 2023 | 28 | 0.060 |
Why?
|
Prone Position | 1 | 2024 | 196 | 0.060 |
Why?
|
Depth Perception | 1 | 2023 | 94 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8499 | 0.050 |
Why?
|
New South Wales | 1 | 2023 | 70 | 0.050 |
Why?
|
School Admission Criteria | 1 | 2024 | 105 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6362 | 0.050 |
Why?
|
Sunscreening Agents | 1 | 2024 | 139 | 0.050 |
Why?
|
Perioperative Period | 1 | 2024 | 262 | 0.050 |
Why?
|
Journal Impact Factor | 1 | 2024 | 153 | 0.050 |
Why?
|
Collagenases | 1 | 2023 | 221 | 0.050 |
Why?
|
Verapamil | 1 | 2023 | 242 | 0.050 |
Why?
|
Carbamazepine | 1 | 2023 | 224 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15225 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20500 | 0.050 |
Why?
|
Hospitals, Public | 1 | 2024 | 201 | 0.050 |
Why?
|
Oxycodone | 1 | 2023 | 138 | 0.050 |
Why?
|
Ukraine | 1 | 2022 | 138 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2023 | 304 | 0.050 |
Why?
|
Bandages | 1 | 2023 | 269 | 0.050 |
Why?
|
Publication Bias | 1 | 2022 | 161 | 0.050 |
Why?
|
Russia | 1 | 2022 | 381 | 0.050 |
Why?
|
Systole | 1 | 2024 | 936 | 0.050 |
Why?
|
Health Occupations | 1 | 2023 | 222 | 0.050 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2359 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2023 | 348 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5649 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 315 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2023 | 362 | 0.050 |
Why?
|
Pharynx | 1 | 2023 | 432 | 0.040 |
Why?
|
Bibliometrics | 1 | 2024 | 349 | 0.040 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2877 | 0.040 |
Why?
|
Nausea | 1 | 2023 | 677 | 0.040 |
Why?
|
Vasoconstriction | 1 | 2023 | 592 | 0.040 |
Why?
|
Thinness | 1 | 2023 | 490 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5484 | 0.040 |
Why?
|
National Health Programs | 1 | 2023 | 441 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 413 | 0.040 |
Why?
|
Nose | 1 | 2023 | 519 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2023 | 1593 | 0.040 |
Why?
|
Video Recording | 1 | 2024 | 954 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 463 | 0.040 |
Why?
|
Confidentiality | 1 | 2023 | 610 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12075 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 838 | 0.040 |
Why?
|
Automation | 1 | 2021 | 580 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1565 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2023 | 600 | 0.040 |
Why?
|
Netherlands | 1 | 2023 | 2212 | 0.040 |
Why?
|
Peer Group | 1 | 2024 | 677 | 0.040 |
Why?
|
Veins | 1 | 2023 | 765 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2019 | 250 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2023 | 1044 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1599 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2111 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 829 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2023 | 836 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15399 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2023 | 1130 | 0.040 |
Why?
|
Photic Stimulation | 1 | 2023 | 1967 | 0.040 |
Why?
|
Cisplatin | 1 | 2023 | 1645 | 0.040 |
Why?
|
Informed Consent | 1 | 2023 | 1003 | 0.040 |
Why?
|
Cohort Studies | 3 | 2024 | 41256 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3420 | 0.030 |
Why?
|
Subthalamic Nucleus | 1 | 2019 | 195 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10146 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2024 | 1192 | 0.030 |
Why?
|
Colonoscopy | 1 | 2023 | 1388 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1090 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15651 | 0.030 |
Why?
|
Specialization | 1 | 2019 | 776 | 0.030 |
Why?
|
Visual Acuity | 1 | 2024 | 2642 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2024 | 2047 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2189 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2500 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21272 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2650 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7225 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2024 | 1911 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3671 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2714 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2671 | 0.020 |
Why?
|
Adolescent | 2 | 2019 | 87892 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3812 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 4962 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3069 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10504 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9650 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5460 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3312 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2311 | 0.020 |
Why?
|
Animals | 2 | 2024 | 167768 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3526 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 58808 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2024 | 2142 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10495 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3846 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3364 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4539 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8451 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3806 | 0.020 |
Why?
|
Sleep | 1 | 2023 | 4744 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7985 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5816 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9160 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20055 | 0.020 |
Why?
|
Child | 2 | 2023 | 79818 | 0.020 |
Why?
|
Quality of Life | 1 | 2023 | 13285 | 0.010 |
Why?
|
Heart Failure | 1 | 2024 | 11593 | 0.010 |
Why?
|